588 related articles for article (PubMed ID: 19127138)
61. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
62. Drug interactions between proton pump inhibitors and antiretroviral drugs.
McCabe SM; Smith PF; Ma Q; Morse GD
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):197-207. PubMed ID: 17428151
[TBL] [Abstract][Full Text] [Related]
63. [Adverse effects of proton pump inhibitors: should we worry about long-term exposure?].
Roulet L; Vernaz N; Giostra E; Gasche Y; Desmeules J
Rev Med Interne; 2012 Aug; 33(8):439-45. PubMed ID: 22284952
[TBL] [Abstract][Full Text] [Related]
64. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women.
Prescrire Int; 2009 Dec; 18(104):250. PubMed ID: 20025090
[TBL] [Abstract][Full Text] [Related]
65. Safety of the long-term use of proton pump inhibitors.
Thomson AB; Sauve MD; Kassam N; Kamitakahara H
World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
[TBL] [Abstract][Full Text] [Related]
66. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease.
Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y
J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288
[TBL] [Abstract][Full Text] [Related]
67. Proton pump inhibitors and gastric neoplasia.
Kuipers EJ
Gut; 2006 Sep; 55(9):1217-21. PubMed ID: 16905689
[TBL] [Abstract][Full Text] [Related]
68. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
Rew JS
Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
[TBL] [Abstract][Full Text] [Related]
69. [Proton pump inhibitors: not as safe as they seem].
van Herwaarden N; Bos JM; Veldman B; Kramers C
Ned Tijdschr Geneeskd; 2016; 160():D487. PubMed ID: 27438396
[TBL] [Abstract][Full Text] [Related]
70. Proton pump inhibitor use in infants: FDA reviewer experience.
Chen IL; Gao WY; Johnson AP; Niak A; Troiani J; Korvick J; Snow N; Estes K; Taylor A; Griebel D
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):8-14. PubMed ID: 21946832
[TBL] [Abstract][Full Text] [Related]
71. Acid secretion from birth to adulthood.
Boyle JT
J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S12-6. PubMed ID: 14685072
[TBL] [Abstract][Full Text] [Related]
72. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
73. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
El-Serag HB; Fitzgerald S; Richardson P
Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
[TBL] [Abstract][Full Text] [Related]
74. Proton Pump Inhibitors: What the Internist Needs to Know.
Spechler SJ
Med Clin North Am; 2019 Jan; 103(1):1-14. PubMed ID: 30466666
[TBL] [Abstract][Full Text] [Related]
75. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
76. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
Bordin DS; Masharova AA
Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
[No Abstract] [Full Text] [Related]
77. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
Cundy T; Dissanayake A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
[TBL] [Abstract][Full Text] [Related]
78. Hold it! Are you taking your reflux meds correctly? PPIs for heartburn and GERD are effective--but only when used according to directions.
Johns Hopkins Med Lett Health After 50; 2014 Oct; 26(10):3. PubMed ID: 25306565
[No Abstract] [Full Text] [Related]
79. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations.
Koyyada A
Therapie; 2021; 76(1):13-21. PubMed ID: 32718584
[TBL] [Abstract][Full Text] [Related]
80. Clinical implications of chronic therapy for GERD. Preface.
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S1. PubMed ID: 19262539
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
